Since Meller (2005) [8] first reported the protective effects of OPN in middle cerebral artery occlusion (MCAO) using OPN-deficient mice, numerous reports have demonstrated the neuroprotective effects of OPN in various stroke animal models [9,10,11]. This evidence concerns the gene SPP1 and stroke disorder.